Bilateral Pneumonectomy + Lung Transplant with Dynamic ECMO Support (DREAM-style strategy)

Conceptual Framework: Bilateral Pneumonectomy + Lung Transplant with Dynamic ECMO Support (DREAM-style strategy)

1. Clinical Context & Rationale

This scenario typically applies to:

* End-stage bilateral lung malignancy confined to thorax (selected cases only)
* No viable native lung preservation strategy
* Need for complete cardiopulmonary support during en bloc lung removal and implantation
* Goal: maintain systemic perfusion while controlling pulmonary circulation entirely extracorporeally

Key principle:

You are temporarily replacing both lungs as gas exchange organs while preserving hemodynamics and right/left heart stability during sequential anatomic elimination of native lungs.

⸻

2. Preoperative Platform (Core Setup)

Cannulation strategy (central ECMO initiation)

* Central aortic cannulation (or ascending aorta)
* Dual venous drainage (RA + IVC or bi-caval)
* Right atrial return

This establishes initial:

* VVA ECMO configuration
* Venous drainage → oxygenator → venous + arterial reinfusion support

Purpose:

* Full cardiopulmonary bypass-like stability without full CPB inflammatory profile
* Allows controlled hemodynamic takeover before thoracic dissection

⸻

3. Phase I: Initiation of Central VVA ECMO

Goals:

* Stabilize oxygenation and systemic perfusion before lung exclusion
* Decompress right heart under controlled preload reduction
* Enable safe mediastinal and hilar dissection

Physiology:

* Mixed venous return oxygenation support
* Partial arterial support prevents RV strain during pulmonary manipulation

⸻

4. Phase II: Bilateral Pneumonectomy (Native Lung Exclusion Phase)

Key concept:

Native lungs become non-functional or actively harmful (malignant, non-ventilatable, or bleeding source)

Surgical endpoint:

* Complete bilateral hilar control and removal of both lungs
* Airway management at tracheal level depending on sequence strategy

ECMO implication:

* Transition toward VAV configuration
* Venous drainage maintained
* Arterial support maintained
* Additional venous reinfusion to optimize oxygen delivery

Why VAV here:

* Prevents differential hypoxia
* Stabilizes coronary and cerebral oxygenation during absent lung phase
* Provides balanced preload/afterload management

⸻

5. Phase III: Implantation Phase (Lung Graft Implantation)

During sequential implantation (right then left or vice versa depending on center strategy):

Physiologic challenges:

* Loss of native pulmonary vascular bed
* Sudden shifts in right ventricular afterload
* Risk of reperfusion instability

ECMO strategy:

* Gradual reduction of arterial ECMO support
* Maintenance of venous drainage + oxygenation

⸻

6. Phase IV: Transition to VV ECMO

Once:

* Graft lungs are implanted
* Pulmonary anastomoses are completed
* Early graft perfusion is stable

Transition:

* Convert from VAV → VV ECMO

VV ECMO role:

* Pure respiratory support only
* Cardiovascular system now fully self-sustaining via native heart + new lungs

Physiology:

* Right heart now ejects into functional pulmonary grafts
* ECMO only supports oxygenation during early graft edema / reperfusion injury phase

⸻

7. Phase V: Weaning from ECMO

Criteria-driven rather than time-driven:

* Stable graft oxygenation (PaO₂/FiO₂ improving trend)
* Acceptable pulmonary vascular resistance
* No significant right ventricular dysfunction
* Adequate gas exchange off-flow trials

Weaning sequence:

* Reduce VV flow → clamp trials → decannulation

⸻

8. Special Considerations in Active Lung Malignancy

This is the most critical aspect of your scenario.

Key oncologic constraints:

* Ensure no extrapulmonary metastasis
* Strict intraoperative oncologic clearance margins
* Avoid tumor spillage during hilar dissection
* En bloc vs sequential resection decision depends on tumor burden

Important principle:

Transplant in malignancy is only considered in extremely selected “confined thoracic disease” or experimental protocols.

⸻

9. DREAM Strategy Interpretation (Conceptual)

If we interpret “DREAM project” as a staged advanced transplant platform:

* D: Devascularization (controlled hilar isolation under ECMO)
* R: Removal (bilateral pneumonectomy)
* E: Extracorporeal support modulation (VVA → VAV → VV)
* A: Allograft implantation
* M: Metabolic recovery & weaning

⸻

10. Core Physiologic Philosophy

The entire strategy is built on:

* Maintaining systemic oxygen delivery independent of lungs
* Gradual reintroduction of pulmonary circulation via grafts
* Dynamic ECMO adaptation to each anatomic phase
* Protecting right ventricle from abrupt afterload transitions